A Brief History of Homeoprophylaxis in Cuba, 2004–2014

Abstract

Homeoprophylaxis (HP) was first used by Hahnemann in 1798, and has been used around the world against most infectious diseases since then. The Cuban experience with HP has become widely known, and is totally unique in that it has mainly been undertaken by doctors and scientists from a scientific institute that researched and sold vaccines. It gave a level of credibility that was often denied to research by lay homeopaths. It also described the use of HP in literally millions of people as well as in smaller settings. This article provides a brief summary of the Cuban experience with HP from 2004 to 2014.

Keywords

homeoprophylaxis - Cuba - cholera - dengue fever - hepatitis A - leptospirosis - pneumococcal disease - swine flu - viral conjunctivitis

• References

• 1 Bracho G, Varela E, Ferna'ndez R , et al. Large-scale application of highly diluted bacteria as homeoprophylactic formulation for leptospirosis epidemic control. Homeopathy 2010; 99: 156-166
• 2 Golden I, Bracho G. A reevaluation of the effectiveness of homoeoprophylaxis against leptospirosis in Cuba in 2007 and 2008. J Evid Based Complementary Altern Med 2014; 19 (3) 155-160
• 3 Misra S. Randomized double blind placebo control studies, the “gold standard” in intervention-based studies. Indian J Sex Transm Dis 2012; 33 (2) 131-134
• 4 Uman LS. Systematic reviews and meta-analyses. J Can Acad Child Adolesc Psychiatry 2011; 20 (1) 57-59
• 5 If only from reports from regulators withdrawing drugs previously approved on the basis of RCTs due to safety and effectiveness outcomes not apparent from the trials
• 6 Ioannidis JPA. Why most published research findings are false. PLoS Med 2005; 2 (8) e124
• 7 Walach H. The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. J Altern Complement Med 2001; 7 (3) 213-218
• 8 Golden I. Beyond randomized controlled trials: evidence in complementary medicine. J Evid Based Complementary Altern Med 2012; 17 (1) 72-75
• 9 Department of Health. The Australian Immunisation Handbook. 10th ed. Section 4.9.4 vaccines. 2015. http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home~handbook10part4~handbook10-4-9#4-9-4 . Accessed February 26, 2106
• 10 Puri A, Gupta VK, Chakravarti A, Mehra M. Measles vaccine efficacy evaluated by case reference technique. Indian Pediatr 2002; 39 (6) 556-560
• 11 Poland GA, Jacobson RM. The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines?. Vaccine 2012; 30 (2) 103-104
• 12 Walach H, Falkenberg T, Fønnebø V, Lewith G, Jonas WB. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. BMC Med Res Methodol 2006; 6 (29) 29
• 13 Matthiessen PF, Bornhoft G , eds. Homeopathy in Healthcare: Effectiveness, Appropriateness, Safety, Costs. Berlin Heidelberg, Germany: Springer-Verlag; 2011
• 14 Press release, Cambridge, MA, September 30, 2013. JLME Issue on Institutional Corruption and the Pharmaceutical Industry. A special issue of the Journal of Law Medicine and Ethics. http://ethics.harvard.edu/news/jlme-issue-institutional-corruption-and-pharmaceutical-industry . Accessed 5 April 2016